Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Boehringer Ingelheim
Accenture
Johnson and Johnson
Cerilliant
Chubb
Baxter
McKesson
Chinese Patent Office

Generated: January 18, 2018

DrugPatentWatch Database Preview

Moxalactam disodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for moxalactam disodium and what is the scope of moxalactam disodium freedom to operate?

Moxalactam disodium
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for moxalactam disodium.
Summary for moxalactam disodium
Medical Subject Heading (MeSH) Categories for moxalactam disodium

US Patents and Regulatory Information for moxalactam disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
UBS
Merck
Medtronic
Dow
Harvard Business School
Healthtrust
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot